News Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Therapy With Intravitreal Ranibizumab (Lucentis) for Naive Retinal Vein Occlusion: 1-year Follow-up by Medscape • 2011/03/18 • 0 Comments How safe and effective is intravitreal ranibizumab in treating retinal vein occlusion? The British Journal of Ophthalmology Full Story →